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addition, three VMAT class solutions were created for this 
patient group covering most of the rectal carcinoma cases, 
reducing the time needed to plan individual treatments. The 
technique has since been implemented clinically at our 
department. 
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Purpose/Objective: Since 2010 the treatment of localized 
skin cancer on the nose is irradiated, in our service, with HDR 
(192Ir) using a custom mold. By the characteristics of the unit, 
guide tubes passing above the patient. The aim of this study 
is to determine if the source path leaves dose at the skin and 
if therefore require special protection. 
Materials and Methods: A skin tumor on the tip of the nose is 
simulated in an anthropomorphic phantom on which a 
customized thermoplastic mold is made with 3 plastic 
catheters placed covering the tumor. Dosimetry was made 
with the BrachyVision 3D (v8.1) treatment planning. To 
determine the dose received we used radiochromic films 
(Grafchromic EBT2); they are placed one on a flat surface 
under a block of expanded polystyrene (8cm thickness) and 
other one over the block, and the three transfer tubes above 
it. Complete treatment, consisting of 18 sessions of 3 Gy, was 
administrated. All films were digitized with an Epson 
Expression 1000XL scanner and analyzed at 24h of irradiation 
using the ImageJ program. Background (fog) was determined 
by an unirradiated film. We measured the mean and standard 
deviation of dose administrated in 3 representative areas 
(150x150 pixels) of each film, and compared between them. 
Results: The film that was in contact with the tubes, in spite 
of the fast speed transfer of the source, indicates that was 
administrated a significant dose to the patient. The film 
under the polystyrene block indicates that the dose was 
decreased considerably. 
Conclusions: To reduce the dose to the patient is useful to 
avoid the contact of the transfer tubes with him. 
The polystyrene blocks, are an easy, cheap and convenient 
method that can reduce significantly the dose received by 
the patient. A study to determine optimum materials and to 
avoid unnecessary irradiation of healthy tissue during 
treatment with HDR is launched with the physics unit. 
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Purpose/Objective: Adjuvant radiotherapy after breast-
conserving surgery for breast cancer implies a risk of late 
cardiac and pulmonary toxicity. This pilot study evaluates 
cardiopulmonary dose sparing of respiratory displacement 
adapted radiotherapy (BART) using free breathing gating. 
Materials and Methods: 30 patients were computed 
tomography (CT) scanned with EIG audio coaching during scan 
and treatment process. Respiration curves were analysed 
with average maximum IL and standard deviation (SD) for the 
EIG part of the respiratory signal. Analysis of dosimetric and 
respiration parameters were performed. 
30 patients were CT-scanned during non-coached breathing 
manouvre including free breathing (FB), end-inspiration 
gating (IG), end-expiration gating (EG). The Varian Real-time 
Position Management system (RPM) was used to monitor 
respiratory movement and to gate the scanner. For each 
breathing phase, a population based internal margin (IM) was 
estimated based on average chest wall displacement, and 
incorporated into an individually optimized isocentric wide 
tangential photon field treatment plan for each scan. 
Treatment plans for 42.4 Gy over 16 fractions were 
calculated. 
Results: The mean anteroposterior body excursion during FB 
was 2.5mm. For IG and EG, the mean excursions within gating 
windows were less at 1mm. The internal margin was reduced 
in 3 mm. and the dose in lung and heart were reduced in a 5% 
Conclusions: This preliminary analysis confirms measurable 
dosimetric benefits for free breathing gated breast cancer 
radiotherapy. 
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Purpose/Objective: At the UHB Radiotherapy department we 
have two TomoTherapy HD units. The QA procedure for 
patients being treated on TomoTherapy (Tomo) is that a 
patient specific delivery QA (DQA) must be carried out prior 
to the patient beginning treatment, using out Delta4 
phantom. For Category 1 patients, a secondary DQA must be 
carried out (known as a transfer plan), so there is one plan 
for each of the two rooms in case of a treatment delivery 
unit breakdown. The Tomo HD units have dynamic jaws 
functionality (known as TomoEDGE) which speeds up the 
delivery time thus enabling us to increase patient 
throughput. More throughput means more time required on 
the machines to carry out DQA. The aim of this project is to 
reduce the workload of patient specific QA on transfer plans. 
The solution should be auditable, safe, secure, maintainable, 
not impact on already deployed clinical software and present 
the required results in a presentable format to attach to 
patient records in our Oncology Management System (OMS), 
MOSAIQ. 
Materials and Methods: The two DICOM Tomo RT plan files 
were validated and interpreted using dcm4chee library and 
private Tomo DICOM tags compared using standard Java 
libraries. A web application was created using the robust 
infrastructure of Enterprise Java Beans (EJB) to allow the 
user to load the two plans for comparison. The sinogram from 
the two plans were compared against each other by taking 
into account the latency differences between the machines. 
As TomoEDGE functionality is used, the jaw positions for each 
projection were also compared. The results of the 
comparison are displayed in the Graphical User Interface 
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(GUI) as a table and graph. The entire program suite was 
developed using Netbeans. 
Results: A robust and maintainable solution has been put in 
place through a web application without interfering with any 
software medical devices. The table of values that have been 
compared against tolerances can be attached as a PDF 
document to the patient records in the OMS. The graphical 
user aspects of the application have been tested with the 
automated testing package, Selenium. This enables future 
modifications in the program to have the vast majority of its 
user interface checked without user intervention. The 
developed application had its business logic tested using 
JUnit4 with 23 representative datasets. This program has the 
capability of reducing the time it takes to carry out patient 
specific QA by removing the need to deliver the transfer plan 
on the second machine, which takes 40 minutes for the first 
patient and 20 minutes for subsequent patients. 
Conclusions: An application has been developed that meet 
the overarching requirements of such medical software. It is 
a reliable independent check on transfer plans. It has 
reduced the need to carry out transfer plan checks on the 
second TomoTherapy machine. It will be running in parallel 
with the QA procedure of checking patient transfer plans and 
then eventually integrated into the QA workflow. 
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Purpose/Objective: Field-in-field (FIF) technique ameliorates 
the conventional planning with tangential fields (TANG) for 
adjuvant treatments of breast cancers. It applies additional 
fields to improve different parameters. Ideally, each 
additional fields should be delivered with perfect alignment 
to the main one. Treating more complex plan solutions for 
such patients affects the daily work of the RTT and implies 
more demanding practicalities. Define the stability of the 
dosimetric gain for the FIF plan when data errors due to the 
misalignment of conventional main fields to each field-in-
field is incorporated, could improve the awareness of 
clinicians, physics and RTTs about such an issue. 
Materials and Methods: We compared FIF technique to the 
corresponding TANG. Endpoints evaluated were: V95, V105, 
Maximum Dose within PTV, Maximum Dose. Separately, the 
misalignment of each specific field-in-field with the 
corresponding conventional main field was acquired directly 
during the treatment delivery (details reported in separately 
submitted abstract). First, the baseline FIF was compared to 
the TANG plan. Then, the FIF was recalculated incorporating 
the misalignment data and the new plan (FIFErrors) was 
compared to the TANG to check the stability of the 
dosimetric gain. A statistical analysis of the significance of 
differences reported on treatment plans between TANG and 
FIF, and between TANG and FIFErrors was separately 
addressed by Wilcoxon. 
Results: We analyzed 33 patients. Mean values for FIF and 
TANG plans, were respectively: V95=98.92 vs 98.25%; 
Maximum Dose= 109.0vs 110.01%; Maximum Dose within PTV= 
108.32 vs 109.01; V105=4.01vs 4.42. The FIF was significantly 
superior to the TANG plan for V95 (p=0.003), Maximum Dose 
(p=0.002), Maximum Dose within PTV (p=0.033); it was not 
significantly superior for V105 (p=0.201) although the mean 
V105 value was overall inferior for the FIF (4.01%FIF vs 4.42% 
TANG). 
Mean values for FIFErrors and TANG respectively were: 
V95=98.90 vs 98.25%; Maximum Dose= 109.8 vs 110.01%; 
Maximum Dose within PTV= 108.39 vs 109.01; V105=4.11vs 
4.42. The FIFErrors was significantly superior to the TANG for 
V95 (p=0.005), Maximum Dose (p=0.003); it was not 
significantly superior for V105 (p=0.326) and for the Maximum 
Dose within PTV (p=0.071) although the mean V105 and 
Maximum Dose within PTV values were overall inferior for the 
FIFplan. The mean gain by the adoption of FIF over the TANG 
accounted for: V95=0.67%; Maximum Dose= 1.01%; Maximum 
Dose within PTV= 0.69%; V105=0.41%. Once recalculated 
considering the misalignment it was reduced by a percentage 
of 2.98% for V95, 10.14% for Maximum Dose; 7.93% for 
Maximum Dose within PTV; 24.39 % for V105, respectively 
Conclusions: FIF technique optimizes the planning, without 
major drawbacks for the RTT practice. Although it presents a 
good geometrical stability during the delivery, it is more 
demanding for the daily practice of the RTT. The risk of waist 
of a rate of the planned gain should be taken into account 
when clinicians and physics select the planning. Close inter-
professional collaboration could improve the whole process of 
planning and daily delivery. 
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Purpose/Objective: As part of Treatment Planning System 
(TPS) QA, the Institute of Physics and Engineering in Medicine 
(Report 61) recommends performing frequent, independent 
integrity checks of all executable, configuration and data 
files.  
Checksum calculations provide a rapid, automated method to 
verify file integrity. They can be performed at a high 
frequency, to minimise delays between change and 
detection. Verifying program integrity via checksums requires 
no knowledge of program function and is operating system 
independent; requiring only a baseline calculation in a known 
working state (commissioning/post-update). 
In a multi-vendor department, a single, unified approach to 
manage file integrity across platforms is desirable, to 
minimise maintenance and management overheads. Whilst 
various systems exist to perform this, they normally require 
the installation of clients, which is undesirable on certified 
Medical Devices. 
Materials and Methods: The Open Source Security (OSSEC) 
Host Intrusion Detection System (Trend Micro, UK) has been 
implemented to perform File Integrity Management (FIM) on 
two TPS (Monaco and XiO, Elekta, Sweden). Natively, OSSEC 
performs integrity checks on Unix/Linux systems without 
components being installed onto target devices, via the 
Secure Shell (SSH) protocol. A parallel system, utilising the 
